Description

Graniforce MD Tablet contains Granisetron as its main active ingredient. Granisetron is a selective 5-HT3 receptor antagonist used in the prevention and treatment of nausea and vomiting induced by chemotherapy and radiation therapy. It is commonly prescribed for patients undergoing cancer treatment. Graniforce MD Tablet works by blocking the action of serotonin, a natural substance in the body that can cause nausea and vomiting. By inhibiting the activation of these receptors, it helps to suppress nausea and vomiting symptoms. The tablet is generally taken orally, with or without food, as directed by the physician. The dosage and duration of treatment may vary depending on the individual’s response and medical condition. Common side effects may include constipation, headache, and dizziness. Graniforce MD Tablet is an effective and widely used medication in managing chemotherapy-induced nausea and vomiting, providing relief to patients undergoing cancer treatment.

Additional information